Copyright
©The Author(s) 2025.
World J Radiol. Apr 28, 2025; 17(4): 105722
Published online Apr 28, 2025. doi: 10.4329/wjr.v17.i4.105722
Published online Apr 28, 2025. doi: 10.4329/wjr.v17.i4.105722
Table 1 Key parameters from ultra-high dose rate flash radiotherapy clinical trials
Trial phase | Tumor type | Dose rate (Gy/s) | Total dose (Gy) | Normal tissue toxicity | Tumor control | Follow-up |
I | Cutaneous | 166 | 15-35 | Reduced skin fibrosis | Comparable | 24 months |
I | Bone metastases | 200 | 8 | Minimal myelopathy | Partial | 9 months |
- Citation: Yang XX, Luo H, Zhang JJ, Ge H, Ge L. Clinical translation of ultra-high dose rate flash radiotherapy: Opportunities, challenges, and prospects. World J Radiol 2025; 17(4): 105722
- URL: https://www.wjgnet.com/1949-8470/full/v17/i4/105722.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i4.105722